Let's Make things Better
JNS: Cipla has introduced Afrezza, India’s first inhalable insulin, following approval from the Central Drugs Standard Control Organisation (CDSCO). Developed by MannKind Corporation in the USA, Afrezza offers a needle-free, …
Cipla Launches India’s First Inhalable Insulin, Afrezza Read More
JNS: The Drugs Controller General of India (DCGI), granted permission of the Emergency Use Authorisation (EUA) of Moderna’s COVID-19 vaccine in India on Tuesday. The DCGI, granted permission to Cipla (a …
Moderna gets government nod for EUA in India Read More
JNS: The price of Remdesivir injection reduced after the government’s intervention on Saturday in a bid to make it more affordable for patients. Several pharma companies have announced to cuts the …
Price of Remdesivir injection reduced to half Read More